ArticleRSC medicinal chemistry2023

Discovery of pyrazolopyrimidines that selectively inhibit CSF-1R kinase by iterative design, synthesis and screening against glioblastoma cells.

Daniel J Baillache et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.